Long Read Sequencing Market Report
RA02135
Long Read Sequencing Market, by Product (Instruments, Consumables, Services), Application (Identification & fine mapping of structural variation, Tandem Repeat Sequencing, Pseudogene discrimination, Resolving allele phasing, Reproductive genomics, Cancer, Viral & Microbial Sequencing, Others), End Use (Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, Other), Technology (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing), Workflow (Pre-sequencing, Sequencing, Data Analysis): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global long read sequencing market is estimated to surpass $5,213.1 million by 2027, exhibiting a CAGR of 23.5% from 2020 to 2027.
The report offers thorough analysis of the global long read sequencing market by meticulously studying different aspects of the market including market dynamics, major segments, growth opportunities, regional market conditions, and leading players operating in the market.
This research report sheds a light on the current market scenario and upcoming trends & developments predicted to contribute for the global market growth during the forecast period. In addition, key market drivers and opportunities boosting the market growth are delivered in the report. Also, challenges and restraints that hold power to restrict the market growth are also offered in the report. Further, the report offers Porter’s five forces analysis of the market to elucidate factors such as bargaining power of suppliers & buyers, competitive landscape, threats of new players, and the occurrence of substitutes in the market.
The report offers future perspectives and growth outlook of the global long read sequencing market that is based on the key forces molding the market. The report provides market size and forecast by keenly evaluating each segment of the global market. Regional market breakdown of these segments is also offered in the report. The report segments the global long read sequencing market into four major regions including North America, Europe, Asia-Pacific, and LAMEA. Furthermore, these regions are sub-segmented to provide detailed panorama of the long read sequencing market across major countries in specific regions. Moreover, the report includes some of the recent developments, trends, and future opportunities in each region.
Furthermore, the report highlights the major players functioning in the global long read sequencing market. A detailed overview of top 10 players operating in the global long read sequencing market is provided in the report for understanding their status and foothold over the market share. Company profile of each player includes several data points such as short overview of the company, major company executives, company’s financial status and revenue, major business strategies implemented by company, innovative developments or initiatives taken by company to shove their position and standout among other competitors in the global long read sequencing market.
RESEARCH METHODOLOGY
Research Dive offers its clients extensive research and analysis gleaned from wide variety of factual inputs that largely includes interview with participants of the industry, reliable data & statistics, and regional intelligence. The in-house experts of the industry play a crucial role in designing analytic tools and models, tailor-made to the requests of an industry segment. The data and statistics are sterilized with these analytical tools and models, which enhances the accuracy of our advice and recommendations.
This research report is delivered by Research Dive by conducting long hours of discussions and interviews, with a broad range of stakeholders, which includes upstream and downstream participants. Our analysts have performed a mix of primary and secondary research for the market estimations and forecasts. A number of product type literatures, industry releases, annual reports, and other related documents of major participants of the industry have been reviewed, to better understand the global long read sequencing market scenario. The initial phase of our in-depth study, where we perform wide-range data mining, referring to proficient & verified data sources such as independent studies, medical journals, technical journals, releases by trade association, materials published by government & regulatory authorities, and other.
KEY MARKET BENEFITS
- The report is a compilation of detailed information, inputs from industry participants and industry experts across the value chain, and quantitative and qualitative assessment by industry analysts
- This report provides in-depth analysis of current market trends, governing factors, macro-economic indicators from 2019 to 2027 to identify & understand the prevailing opportunities and the strategic assessment of the growth of the global long read sequencing market
- The report maps the qualitative sway of various industry factors on market segments as well as geographies
- The market estimations and size provided in the report are based on a comprehensive analysis of recent & futuristic key developments in the long read sequencing market
- The growth and development strategies adopted by the prominent industry players are enlisted in the report to understand the competitive scenario of the long read sequencing market
KEY MARKET SEGMENTS
The market has been studied based on the following segments:
- Product: Instruments, Consumables, Services
- Application: Identification & fine mapping of structural variation, Tandem Repeat Sequencing, Pseudogene discrimination, Resolving allele phasing, Reproductive genomics, Cancer, Viral & Microbial Sequencing, Others
- End Use: Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, Other
- Technology: Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing
- Workflow: Pre-sequencing, Sequencing, Data Analysis
Region:
The global long read sequencing market is divided into North America, Europe, Asia Pacific, and LAMEA.
The above-mentioned regions are further dived in countries as follows:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA
KEY PLAYERS
The key players profiled in the report are Genome Transcriptome Facility of Bordeaux, , , Oxford Nanopore Technologies Limited.
The report outlines the business overview including financial performance, latest strategic moves & developments, product portfolio, and SWOT analysis of the leading players of the long read sequencing market.
1. Oxford Nanopore Technologies Limited
2. Pacific Biosciences of California
3. Inc.
4. Quantapore, Inc.
5. Stratos Genomics, Inc.
6. MicrobesNG
7. Institute of Integrative Biology of the Cell (I2BC)
8. BaseClear B.V.
9. Future Genomics Technologies B.V.
10. Garvan Institute of Medical Research
11. Genome Transcriptome Facility of Bordeaux
12.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Long Read Sequencing Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Long Read Sequencing Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Long Read Sequencing Market, By Product
5.1. Overview
5.2 Instruments
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Consumables
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Services
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Research Dive Exclusive Insights
5.5.1 Market attractiveness
5.5.2 Competition heatmap
-
6. Long Read Sequencing Market, By Device Type
6.1. Overview
6.2 Identification & fine mapping of structural variation
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Tandem Repeat Sequencing
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Pseudogene discrimination
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Resolving allele phasing
6.5.1 Definition, key trends, growth factors, and opportunities
6.5.2 Market size analysis, by region, 2020-2027
6.5.3 Market share analysis, by country, 2020-2027
6.6 Reproductive genomics
6.6.1 Definition, key trends, growth factors, and opportunities
6.6.2 Market size analysis, by region, 2020-2027
6.6.3 Market share analysis, by country, 2020-2027
6.7 Cancer
6.7.1 Definition, key trends, growth factors, and opportunities
6.7.2 Market size analysis, by region, 2020-2027
6.7.3 Market share analysis, by country, 2020-2027
6.8 Viral & Microbial Sequencing
6.8.1 Definition, key trends, growth factors, and opportunities
6.8.2 Market size analysis, by region, 2020-2027
6.8.3 Market share analysis, by country, 2020-2027
6.9 Others
6.9.1 Definition, key trends, growth factors, and opportunities
6.9.2 Market size analysis, by region, 2020-2027
6.9.3 Market share analysis, by country, 2020-2027
6.10 Research Dive Exclusive Insights
6.10.1 Market attractiveness
6.10.2 Competition heatmap
-
7. Long Read Sequencing Market, By Type
7.1. Overview
7.2 Academic Research
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Clinical Research
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Hospitals & Clinics
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Pharma & Biotech Entities
7.5.1 Definition, key trends, growth factors, and opportunities
7.5.2 Market size analysis, by region, 2020-2027
7.5.3 Market share analysis, by country, 2020-2027
7.6 Other
7.6.1 Definition, key trends, growth factors, and opportunities
7.6.2 Market size analysis, by region, 2020-2027
7.6.3 Market share analysis, by country, 2020-2027
7.7 Research Dive Exclusive Insights
7.7.1 Market attractiveness
7.7.2 Competition heatmap
-
8. Long Read Sequencing Market, By Type Of Vaccine
8.1. Overview
8.2 Single-Molecule Real-Time Sequencing (SMRT)
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 Nanopore Sequencing
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Research Dive Exclusive Insights
8.4.1 Market attractiveness
8.4.2 Competition heatmap
-
9. Long Read Sequencing Market, By Size By Level
9.1. Overview
9.2 Pre-sequencing
9.2.1 Definition, key trends, growth factors, and opportunities
9.2.2 Market size analysis, by region, 2020-2027
9.2.3 Market share analysis, by country, 2020-2027
9.3 Sequencing
9.3.1 Definition, key trends, growth factors, and opportunities
9.3.2 Market size analysis, by region, 2020-2027
9.3.3 Market share analysis, by country, 2020-2027
9.4 Data Analysis
9.4.1 Definition, key trends, growth factors, and opportunities
9.4.2 Market size analysis, by region, 2020-2027
9.4.3 Market share analysis, by country, 2020-2027
9.5 Research Dive Exclusive Insights
9.5.1 Market attractiveness
9.5.2 Competition heatmap
10. Long Read Sequencing Market, By Region
10.1 North America
10.1.1 U.S
10.1.1.1 Market size analysis, By Product, 2020-2027
10.1.1.2 Market size analysis, By Device Type, 2020-2027
10.1.1.3 Market size analysis, By Type, 2020-2027
10.1.1.4 Market size analysis, By Type of Vaccine, 2020-2027
10.1.1.5 Market size analysis, By Size by Level, 2020-2027
10.1.2 Canada
10.1.2.1 Market size analysis, By Product, 2020-2027
10.1.2.2 Market size analysis, By Device Type, 2020-2027
10.1.2.3 Market size analysis, By Type, 2020-2027
10.1.2.4 Market size analysis, By Type of Vaccine, 2020-2027
10.1.2.5 Market size analysis, By Size by Level, 2020-2027
10.1.3 Mexico
10.1.3.1 Market size analysis, By Product, 2020-2027
10.1.3.2 Market size analysis, By Device Type, 2020-2027
10.1.3.3 Market size analysis, By Type, 2020-2027
10.1.3.4 Market size analysis, By Type of Vaccine, 2020-2027
10.1.3.5 Market size analysis, By Size by Level, 2020-2027
10.1.4 Research Dive Exclusive Insights
10.1.4.1 Market attractiveness
10.1.4.2 Competition heatmap
10.2 Europe
10.2.1 Germany
10.2.1.1 Market size analysis, By Product, 2020-2027
10.2.1.2 Market size analysis, By Device Type, 2020-2027
10.2.1.3 Market size analysis, By Type, 2020-2027
10.2.1.4 Market size analysis, By Type of Vaccine, 2020-2027
10.2.1.5 Market size analysis, By Size by Level, 2020-2027
10.2.2 UK
10.2.2.1 Market size analysis, By Product, 2020-2027
10.2.2.2 Market size analysis, By Device Type, 2020-2027
10.2.2.3 Market size analysis, By Type, 2020-2027
10.2.2.4 Market size analysis, By Type of Vaccine, 2020-2027
10.2.2.5 Market size analysis, By Size by Level, 2020-2027
10.2.3 France
10.2.3.1 Market size analysis, By Product, 2020-2027
10.2.3.2 Market size analysis, By Device Type, 2020-2027
10.2.3.3 Market size analysis, By Type, 2020-2027
10.2.3.4 Market size analysis, By Type of Vaccine, 2020-2027
10.2.3.5 Market size analysis, By Size by Level, 2020-2027
10.2.4 Spain
10.2.4.1 Market size analysis, By Product, 2020-2027
10.2.4.2 Market size analysis, By Device Type, 2020-2027
10.2.4.3 Market size analysis, By Type, 2020-2027
10.2.4.4 Market size analysis, By Type of Vaccine, 2020-2027
10.2.4.5 Market size analysis, By Size by Level, 2020-2027
10.2.5 Italy
10.2.5.1 Market size analysis, By Product, 2020-2027
10.2.5.2 Market size analysis, By Device Type, 2020-2027
10.2.5.3 Market size analysis, By Type, 2020-2027
10.2.5.4 Market size analysis, By Type of Vaccine, 2020-2027
10.2.5.5 Market size analysis, By Size by Level, 2020-2027
10.2.6 Rest of Europe
10.2.6.1 Market size analysis, By Product, 2020-2027
10.2.6.2 Market size analysis, By Device Type, 2020-2027
10.2.6.3 Market size analysis, By Type, 2020-2027
10.2.6.4 Market size analysis, By Type of Vaccine, 2020-2027
10.2.6.5 Market size analysis, By Size by Level, 2020-2027
10.2.7 Research Dive Exclusive Insights
10.2.7.1 Market attractiveness
10.2.7.2 Competition heatmap
10.3 Asia-Pacific
10.3.1 China
10.3.1.1 Market size analysis, By Product, 2020-2027
10.3.1.2 Market size analysis, By Device Type, 2020-2027
10.3.1.3 Market size analysis, By Type, 2020-2027
10.3.1.4 Market size analysis, By Type of Vaccine, 2020-2027
10.3.1.5 Market size analysis, By Size by Level, 2020-2027
10.3.2 Japan
10.3.2.1 Market size analysis, By Product, 2020-2027
10.3.2.2 Market size analysis, By Device Type, 2020-2027
10.3.2.3 Market size analysis, By Type, 2020-2027
10.3.2.4 Market size analysis, By Type of Vaccine, 2020-2027
10.3.2.5 Market size analysis, By Size by Level, 2020-2027
10.3.3 India
10.3.3.1 Market size analysis, By Product, 2020-2027
10.3.3.2 Market size analysis, By Device Type, 2020-2027
10.3.3.3 Market size analysis, By Type, 2020-2027
10.3.3.4 Market size analysis, By Type of Vaccine, 2020-2027
10.3.3.5 Market size analysis, By Size by Level, 2020-2027
10.3.4 Australia
10.3.4.1 Market size analysis, By Product, 2020-2027
10.3.4.2 Market size analysis, By Device Type, 2020-2027
10.3.4.3 Market size analysis, By Type, 2020-2027
10.3.4.4 Market size analysis, By Type of Vaccine, 2020-2027
10.3.4.5 Market size analysis, By Size by Level, 2020-2027
10.3.5 South Korea
10.3.5.1 Market size analysis, By Product, 2020-2027
10.3.5.2 Market size analysis, By Device Type, 2020-2027
10.3.5.3 Market size analysis, By Type, 2020-2027
10.3.5.4 Market size analysis, By Type of Vaccine, 2020-2027
10.3.5.5 Market size analysis, By Size by Level, 2020-2027
10.3.6 Rest of Asia-Pacific
10.3.6.1 Market size analysis, By Product, 2020-2027
10.3.6.2 Market size analysis, By Device Type, 2020-2027
10.3.6.3 Market size analysis, By Type, 2020-2027
10.3.6.4 Market size analysis, By Type of Vaccine, 2020-2027
10.3.6.5 Market size analysis, By Size by Level, 2020-2027
10.3.7 Research Dive Exclusive Insights
10.3.7.1 Market attractiveness
10.3.7.2 Competition heatmap
10.4 LAMEA
10.4.1 Brazil
10.4.1.1 Market size analysis, By Product, 2020-2027
10.4.1.2 Market size analysis, By Device Type, 2020-2027
10.4.1.3 Market size analysis, By Type, 2020-2027
10.4.1.4 Market size analysis, By Type of Vaccine, 2020-2027
10.4.1.5 Market size analysis, By Size by Level, 2020-2027
10.4.2 Saudi Arabia
10.4.2.1 Market size analysis, By Product, 2020-2027
10.4.2.2 Market size analysis, By Device Type, 2020-2027
10.4.2.3 Market size analysis, By Type, 2020-2027
10.4.2.4 Market size analysis, By Type of Vaccine, 2020-2027
10.4.2.5 Market size analysis, By Size by Level, 2020-2027
10.4.3 UAE
10.4.3.1 Market size analysis, By Product, 2020-2027
10.4.3.2 Market size analysis, By Device Type, 2020-2027
10.4.3.3 Market size analysis, By Type, 2020-2027
10.4.3.4 Market size analysis, By Type of Vaccine, 2020-2027
10.4.3.5 Market size analysis, By Size by Level, 2020-2027
10.4.4 South Africa
10.4.4.1 Market size analysis, By Product, 2020-2027
10.4.4.2 Market size analysis, By Device Type, 2020-2027
10.4.4.3 Market size analysis, By Type, 2020-2027
10.4.4.4 Market size analysis, By Type of Vaccine, 2020-2027
10.4.4.5 Market size analysis, By Size by Level, 2020-2027
10.4.5 Rest of LAMEA
10.4.5.1 Market size analysis, By Product, 2020-2027
10.4.5.2 Market size analysis, By Device Type, 2020-2027
10.4.5.3 Market size analysis, By Type, 2020-2027
10.4.5.4 Market size analysis, By Type of Vaccine, 2020-2027
10.4.5.5 Market size analysis, By Size by Level, 2020-2027
10.4.6 Research Dive Exclusive Insights
10.4.6.1 Market attractiveness
10.4.6.2 Competition heatmap
11. Competitive Landscape
11.1 Top winning strategies, 2020-2027
11.1.1 By strategy
11.1.2 By year
11.2 Strategic overview
11.3 Market share analysis, 2020-2027
12. Company Profiles
12.1 Oxford Nanopore Technologies Limited
12.1.1 Overview
12.1.2 Business segments
12.1.3 Product portfolio
12.1.4 Financial performance
12.1.5 Recent developments
12.1.6 SWOT analysis
12.2 Pacific Biosciences of California
12.2.1 Overview
12.2.2 Business segments
12.2.3 Product portfolio
12.2.4 Financial performance
12.2.5 Recent developments
12.2.6 SWOT analysis
12.3 Inc.
12.3.1 Overview
12.3.2 Business segments
12.3.3 Product portfolio
12.3.4 Financial performance
12.3.5 Recent developments
12.3.6 SWOT analysis
12.4 Quantapore, Inc.
12.4.1 Overview
12.4.2 Business segments
12.4.3 Product portfolio
12.4.4 Financial performance
12.4.5 Recent developments
12.4.6 SWOT analysis
12.5 Stratos Genomics, Inc.
12.5.1 Overview
12.5.2 Business segments
12.5.3 Product portfolio
12.5.4 Financial performance
12.5.5 Recent developments
12.5.6 SWOT analysis
12.6 MicrobesNG
12.6.1 Overview
12.6.2 Business segments
12.6.3 Product portfolio
12.6.4 Financial performance
12.6.5 Recent developments
12.6.6 SWOT analysis
12.7 Institute of Integrative Biology of the Cell (I2BC)
12.7.1 Overview
12.7.2 Business segments
12.7.3 Product portfolio
12.7.4 Financial performance
12.7.5 Recent developments
12.7.6 SWOT analysis
12.8 BaseClear B.V.
12.8.1 Overview
12.8.2 Business segments
12.8.3 Product portfolio
12.8.4 Financial performance
12.8.5 Recent developments
12.8.6 SWOT analysis
12.9 Future Genomics Technologies B.V.
12.9.1 Overview
12.9.2 Business segments
12.9.3 Product portfolio
12.9.4 Financial performance
12.9.5 Recent developments
12.9.6 SWOT analysis
12.10 Garvan Institute of Medical Research
12.10.1 Overview
12.10.2 Business segments
12.10.3 Product portfolio
12.10.4 Financial performance
12.10.5 Recent developments
12.10.6 SWOT analysis
12.11 Genome Transcriptome Facility of Bordeaux
12.11.1 Overview
12.11.2 Business segments
12.11.3 Product portfolio
12.11.4 Financial performance
12.11.5 Recent developments
12.11.6 SWOT analysis
12.12
12.12.1 Overview
12.12.2 Business segments
12.12.3 Product portfolio
12.12.4 Financial performance
12.12.5 Recent developments
12.12.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
